The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection - PubMed (original) (raw)
Review
doi: 10.1189/jlb.0403176. Epub 2003 Aug 21.
Affiliations
- PMID: 12960238
- DOI: 10.1189/jlb.0403176
Review
The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection
Massimo Alfano et al. J Leukoc Biol. 2003 Nov.
Abstract
The binding of urokinase-type plasminogen activator (uPA) to its glycosyl-phosphatidyl-inositol (GPI) anchored receptor (uPAR) mediates a variety of functions in terms of vascular homeostasis, inflammation and tissue repair. Both uPA and uPAR, as well as their soluble forms detectable in plasma and other body fluids, represent markers of cancer development and metastasis, and they have been recently described as predictors of human immunodeficiency virus (HIV) disease progression, independent of CD4+ T cell counts and viremia. A direct link between the uPA/uPAR system and HIV infection was earlier proposed in terms of cleavage of gp120 envelope by uPA. More recently, a negative regulatory effect on both acutely and chronically infected cells has been linked to the noncatalytic portion of uPA, also referred to as the amino-terminal fragment (ATF). ATF has also been described as a major CD8+ T cell soluble HIV suppressor factor. In chronically infected promonocytic U1 cells this inhibitory effect is exerted at the very late stages of the virus life cycle, involving virion budding and entrapment in intracytoplasmic vacuoles, whereas its mechanism of action in acutely infected cells remains to be defined. Since uPAR is a GPI-anchored receptor it requires association with a signaling-transducing component and different partners, which include CD11b/CD18 integrin and a G-protein coupled receptor homologous to that for the bacterial chemotactic peptide formyl-methionyl-leucyl-phenylalanine. Which signaling coreceptor(s) is(are) responsible for uPA-dependent anti-HIV effect remains currently undefined.
Similar articles
- Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion.
Elia C, Cassol E, Sidenius N, Blasi F, Castagna A, Poli G, Alfano M. Elia C, et al. J Leukoc Biol. 2007 Nov;82(5):1212-20. doi: 10.1189/jlb.0407251. Epub 2007 Aug 17. J Leukoc Biol. 2007. PMID: 17704294 - Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease.
Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Sidenius N, et al. J Neuroimmunol. 2004 Dec;157(1-2):133-9. doi: 10.1016/j.jneuroim.2004.08.038. J Neuroimmunol. 2004. PMID: 15579290 - Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies.
Floridon C, Nielsen O, Holund B, Sunde L, Westergaard JG, Thomsen SG, Teisner B. Floridon C, et al. Placenta. 1999 Nov;20(8):711-21. doi: 10.1053/plac.1999.0425. Placenta. 1999. PMID: 10527826 Clinical Trial. - Urokinase receptor variants in tissue and body fluids.
Høyer-Hansen G, Lund IK. Høyer-Hansen G, et al. Adv Clin Chem. 2007;44:65-102. Adv Clin Chem. 2007. PMID: 17682340 Review. - Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
Choong PF, Nadesapillai AP. Choong PF, et al. Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S46-58. doi: 10.1097/01.blo.0000093845.72468.bd. Clin Orthop Relat Res. 2003. PMID: 14600592 Review.
Cited by
- Host microRNAs exhibit differential propensity to interact with SARS-CoV-2 and variants of concern.
Capistrano KJ, Richner J, Schwartz J, Mukherjee SK, Shukla D, Naqvi AR. Capistrano KJ, et al. Biochim Biophys Acta Mol Basis Dis. 2023 Feb;1869(2):166612. doi: 10.1016/j.bbadis.2022.166612. Epub 2022 Dec 5. Biochim Biophys Acta Mol Basis Dis. 2023. PMID: 36481486 Free PMC article. - Extracellular ATP induces the rapid release of HIV-1 from virus containing compartments of human macrophages.
Graziano F, Desdouits M, Garzetti L, Podini P, Alfano M, Rubartelli A, Furlan R, Benaroch P, Poli G. Graziano F, et al. Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):E3265-73. doi: 10.1073/pnas.1500656112. Epub 2015 Jun 8. Proc Natl Acad Sci U S A. 2015. PMID: 26056317 Free PMC article. - Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.
Bera A, Zhao S, Cao L, Chiao PJ, Freeman JW. Bera A, et al. PLoS One. 2013 Dec 5;8(12):e82282. doi: 10.1371/journal.pone.0082282. eCollection 2013. PLoS One. 2013. PMID: 24340014 Free PMC article. - Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment.
Rabna P, Andersen A, Wejse C, Oliveira I, Gomes VF, Haaland MB, Aaby P, Eugen-Olsen J. Rabna P, et al. PLoS One. 2012;7(8):e43933. doi: 10.1371/journal.pone.0043933. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22937128 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous